Labquality, supported by Mérieux Equity Partners, acquires Scandinavian CRO
Labquality Corporation acquires Scandinavian CRO (Contract Research Organization), which specializes in clinical trials services for pharmaceutical, medical device, and in vitro diagnostic device companies. They have a strong position in the CRO market both in Sweden and in other Scandinavian countries. As an established and highly distinguished CRO operator in Sweden their customer base covers clients from small and medium sized to large pharmaceutical and medical device companies as well as academia. The acquisition aligns with Labquality’s international growth strategy and enables Labquality to grow its business in Sweden and to enter new markets like Norway and Denmark.
The acquisition enables Labquality to further expand CRO market coverage in the Nordics. “Scandinavian CRO (SCRO) is a great addition to our Labquality family completing our CRO business platform. Now, we are a full service CRO company, and we can continue our geographical expansion and growth. I am very pleased that together with SCRO we share the same passion for quality as we both strive for quality excellence. Moreover, CEO Ulrika Hammarström will contribute to Labquality with her vast and solid leadership experience and knowledge of the CRO business. I look forward to working with her and the SCRO team,” says CEO Juha-Pekka Nuutinen from Labquality.
“I am excited joining forces with the Labquality team. I am confident that we will have excellent opportunities to grow and expand our CRO business together in Scandinavia and beyond. Particularly, I am extremely happy about the matching company cultures and professional teams of both companies. Becoming part of Labquality provides us with the opportunity to strengthen our offering and geographic coverage for our customers. Therefore, we will have a solid CRO platform for building future business growth with like-minded CRO professionals,” concludes Ulrika Hammarström, the founder and CEO of Scandinavian CRO.
The acquisition strengthens Labquality’s position as an expert services provider for the health technology and pharmaceutical industries.
The acquisition does not impact the current customer relationships, partnerships, or personnel of Scandinavian CRO or Labquality.
Download the full press release:
Labquality_Oy_News_19082024
Related articles:
Life Science Sweden
Nordic Life Science
MedWatch
Investors in Healthcare
Dagens Medicin (article available to subscribers)
